Advertisement

Topics

AcelRx Gets $40M in IPO

10:11 EST 11 Feb 2011 |

Redwood City, CA-based AcelRx Pharmaceuticals (NASDAQ: ACRX) said today it has priced its initial public offering. The company sold 8 million shares at $5 apiece, meaning it raised gross proceeds of $40 million. That’s far less than the $12 to $14 per share price range AcelRx had forecasted on Jan. 31. The company, a developer [...]

Original Article: AcelRx Gets $40M in IPO

NEXT ARTICLE

More From BioPortfolio on "AcelRx Gets $40M in IPO"

Advertisement
Quick Search
Advertisement
Advertisement